DE2720995A1 - Optisch aktive s-triazinderivate und ihre verwendung - Google Patents

Optisch aktive s-triazinderivate und ihre verwendung

Info

Publication number
DE2720995A1
DE2720995A1 DE19772720995 DE2720995A DE2720995A1 DE 2720995 A1 DE2720995 A1 DE 2720995A1 DE 19772720995 DE19772720995 DE 19772720995 DE 2720995 A DE2720995 A DE 2720995A DE 2720995 A1 DE2720995 A1 DE 2720995A1
Authority
DE
Germany
Prior art keywords
optically active
triazine derivative
triazine
derivative according
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19772720995
Other languages
German (de)
English (en)
Other versions
DE2720995C2 (OSRAM
Inventor
Naobumi Oi
Hiroo Shimada
Osaka Takatsuki
Hiroshi Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of DE2720995A1 publication Critical patent/DE2720995A1/de
Application granted granted Critical
Publication of DE2720995C2 publication Critical patent/DE2720995C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/50—Two nitrogen atoms with a halogen atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DE19772720995 1976-05-10 1977-05-10 Optisch aktive s-triazinderivate und ihre verwendung Granted DE2720995A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5368276A JPS52136188A (en) 1976-05-10 1976-05-10 Optical active s-triazine derivatives and method for separation and analysis of enantiomer mixture having

Publications (2)

Publication Number Publication Date
DE2720995A1 true DE2720995A1 (de) 1977-11-24
DE2720995C2 DE2720995C2 (OSRAM) 1988-03-24

Family

ID=12949578

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772720995 Granted DE2720995A1 (de) 1976-05-10 1977-05-10 Optisch aktive s-triazinderivate und ihre verwendung

Country Status (3)

Country Link
US (1) US4140496A (OSRAM)
JP (1) JPS52136188A (OSRAM)
DE (1) DE2720995A1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003103A2 (en) * 2003-06-30 2005-01-13 Astrazeneca Ab 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3494105A (en) * 1966-09-16 1970-02-10 Yeda Res & Dev Gas chromatographic resolution of enantiomers bearing an amino group
US4104040A (en) * 1975-02-26 1978-08-01 Sumitomo Chemical Company, Limited Use of s-triazine derivatives in a gas chromatographic method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2891941A (en) * 1956-06-29 1959-06-23 Ciba Ltd Water soluble triazine azo dyestuffs
CS158458B1 (OSRAM) * 1972-05-02 1974-11-25

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3494105A (en) * 1966-09-16 1970-02-10 Yeda Res & Dev Gas chromatographic resolution of enantiomers bearing an amino group
US4104040A (en) * 1975-02-26 1978-08-01 Sumitomo Chemical Company, Limited Use of s-triazine derivatives in a gas chromatographic method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. of Chromatography, 126, 97, 1976 *

Also Published As

Publication number Publication date
JPS5647906B2 (OSRAM) 1981-11-12
US4140496A (en) 1979-02-20
DE2720995C2 (OSRAM) 1988-03-24
JPS52136188A (en) 1977-11-14

Similar Documents

Publication Publication Date Title
DE3788961T2 (de) Verfahren zur herstellung von polysubstituierten diethylentriaminpentaessigsäuren.
DE69524400T2 (de) Neue carbamate und harnstoffderivate als modifikatoren der multidrugresistenz
DE60012656T2 (de) Kristalline salze des dodecyl-2-(n,n-dimethylamino)-propionats
DE2556110C3 (de) 2-(3-Alkylamino-2-hydroxypropoxy)-3cyanpyridine, ihre Herstellung und pharmazeutische Verwendung
DE2300107C2 (de) Vitamin A-Säureanilid-4-carbonsäureäthylester, Verfahren zu seiner Herstellung und diesen enthaltende Zubereitungen
LU84294A1 (de) Pyrrolidinderivate
AT392781B (de) Verfahren zur herstellung von (s)-alpha-ethyl-2- oxo-1-pyrrolidinacetamid
DE3013631A1 (de) Amide der antibiotika aus der gruppe von polyenmakroliden und deren derivate sowie ein verfahren zu deren herstellung
DE69010745T2 (de) Verbindungen und Komplexe, besonders verwendbar für ärztliche Darstellung.
EP3003399B1 (fr) Nouveaux composes chimiques derives de la normemantine et leur utilisation dans le domaine medical
DE19824470A1 (de) Neue Neurokininantagonisten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE69313325T2 (de) Ester von L-Carnitin und Acyl-L-Carnitin, mit entspannender Wirkung, selektiv auf den Gastrointestinaltrakt und sie enthaltende pharmazeutische Zusammensetzungen
DE3856387T2 (de) 1,2,3,4,10,14b-HEXAHYDRODIBENZO-c,f]PYRAZINO-1,2-a]AZEPINO-DERIVATE
DE2720995A1 (de) Optisch aktive s-triazinderivate und ihre verwendung
DE3624376A1 (de) Glycosylamine und deren n-alkyliden-derivate
DE10105014C2 (de) Neues Verfahren zur Herstellung von Monoamiden der DTPA
DE3016831A1 (de) N,n'-di-succinimidyl-, n,n'-diphthalimidyl- und n,n'-bis(5-norbornen-2,3- dicarboxyimidyl)-carbonat, verfahren zur herstellung dieser verbindungen sowie verwendung derselben als reagenz zur herstellung aktiver ester von aminosaeuren
DE1468135A1 (de) Organische Amine und Verfahren zu deren Herstellung
EP0248414A2 (de) Aralkylimidazolderivate
DE69200389T2 (de) Verfahren zur Herstellung von Enantiomeren von 3-Aminchromanderivaten.
DE19816929A1 (de) Neue substituierte Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE69514115T2 (de) Verfahren zur herstellung von levobupivacain und analogue aus l-lysin
DE69616801T2 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE2057718A1 (de) Verfahren zur Herstellung von Carbonsaeureestern
DE2345651A1 (de) Indolylalkylamine und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN

8328 Change in the person/name/address of the agent

Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT. HERMANN, G., DIPL.-PHYS. DR.RER.NAT. SCHMIDT, J., DIPL.-ING. JAENICHEN, H., DIPL.-BIOL. DR.RER.NAT., PAT.-ANWAELTE TREMMEL, H., RECHTSANW., 8000 MUENCHEN